Five Prime Therapeutics, Inc. EPS - Earnings per Share 2013-2020 | FPRX
Five Prime Therapeutics, Inc. eps - earnings per share from 2013 to 2020. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Five Prime Therapeutics, Inc. Annual EPS |
| 2020 |
$-2.29 |
| 2019 |
$-3.92 |
| 2018 |
$-4.13 |
| 2017 |
$-5.38 |
| 2016 |
$-2.44 |
| 2015 |
$9.23 |
| 2014 |
$-1.79 |
| 2013 |
$-5.23 |
| 2012 |
$-23.05 |
| 2011 |
$0.72 |
| 2010 |
$-12.22 |
| Five Prime Therapeutics, Inc. Quarterly EPS |
| 2020-12-31 |
$-0.50 |
| 2020-09-30 |
$-0.74 |
| 2020-06-30 |
$-0.48 |
| 2020-03-31 |
$-0.57 |
| 2019-12-31 |
$-0.88 |
| 2019-09-30 |
$-1.03 |
| 2019-06-30 |
$-0.99 |
| 2019-03-31 |
$-1.02 |
| 2018-12-31 |
$-1.14 |
| 2018-09-30 |
$-1.37 |
| 2018-06-30 |
$-0.99 |
| 2018-03-31 |
$-0.63 |
| 2017-12-31 |
$-1.05 |
| 2017-09-30 |
$-1.54 |
| 2017-06-30 |
$-1.58 |
| 2017-03-31 |
$-1.21 |
| 2016-12-31 |
$-0.74 |
| 2016-09-30 |
$-0.72 |
| 2016-06-30 |
$-0.49 |
| 2016-03-31 |
$-0.49 |
| 2015-12-31 |
$11.05 |
| 2015-09-30 |
$-0.93 |
| 2015-06-30 |
$-0.45 |
| 2015-03-31 |
$-0.44 |
| 2014-12-31 |
$-0.54 |
| 2014-09-30 |
$-0.33 |
| 2014-06-30 |
$-0.46 |
| 2014-03-31 |
$-0.46 |
| 2013-12-31 |
$9.06 |
| 2013-09-30 |
$-2.74 |
| 2013-06-30 |
$-5.82 |
| 2013-03-31 |
$-5.73 |
| 2012-09-30 |
$-4.85 |
